Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Airq Intubating Laryngeal Airway

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07004621Not ApplicableCompletedPrimary

Videolaryngoscopy Versus Direct Laryngoscopy for Endotracheal Intubation of Obese Patients: a Prospective Randomized Trial

NCT00885911CompletedPrimary

Evaluation of the Intubating Laryngeal Airway in Children

NCT01029431Phase 3CompletedPrimary

Evaluation of the Intubating Laryngeal Airway in Children

Showing all 3 trials

Research Network

Common Treatments

  • Airq Intubating Laryngeal Airway1
  • Measurment Of Intubation Time In Seconds1

Active Sponsors

  • University of British Columbia2
  • Jagiellonian University1

Top Investigators

Activity Timeline